Overview

Skip to main content

Latest news
Our company
Careers
Investors
Media center

Development pipeline

Overview

Selecting the value will change the page content

Search by Drug Name. Typing will change the displayed drugs.

Phase 1
Phase 2
Phase 3
Registration

total indications.

Download report (opens in new window)

Questions? Please contact us:

[email protected]

Do Not Sell or Share My Personal Information Limit the Use of My Sensitive Personal Information

ABOUT US

Leadership Team
Office of The Chief Medical Officer
Announcements
Media Center

OUR COMMITMENTS

Code of Business Conduct
Environment, Social, Governance
Sustainability

GET IN TOUCH

Contact Us

Follow us on Youtube
Follow us on Facebook
Follow us on Twitter
Follow us on LinkedIn

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Johnson & Johnson, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Johnson & Johnson to send you the requested Investor Email Alert updates.

* Required

Email address *

Investor alert options

Investor alert options *

News
Quarterly reports
Annual reports
SEC filings
End of day stock quote
Events & presentations

Unsubscribe

Email Alert Sign Up Confirmation

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice.

You should view the News section and the most recent SEC Filings in the Investor sectionin order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.

© Johnson & Johnson Services, Inc.

Careers
Investors
Privacy Policy
Terms of Use
Customize Cookie Settings

Powered By Q4 Inc. 5.120.1.3 (opens in new window)